Evidence map›Paper›PMID 35312343›Full record

ReviewJCO oncology practice2022

Social Media and Professional Development for Oncology Professionals.

Anusha Chidharla, Audun Utengen, Deanna J Attai, Emily K Drake, G J van Londen, Ishwaria M Subbiah, Elizabeth Henry, Martina Murphy, Maura M Barry, Rami Manochakian and 6 more

Abstract readReview
In one paragraph

Review in JCO oncology practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Social media best practices for the spine care professional.North American Spine Society journal · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Use of social media in radiation oncology: multicenter data from the GOCO Group.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Anusha ChidharlaDepartment of Medical Oncology, Kansas University Medical Center, Kansas, KS.ORCID 0000-0001-8611-8875
Audun UtengenSymplur, Real Chemistry, San Francisco, CA.ORCID 0000-0003-4851-269X
Deanna J AttaiDepartment of Surgery, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA.ORCID 0000-0002-1893-1183
Emily K DrakeFaculty of Health, Dalhousie University, Halifax, Nova Scotia, Canada.ORCID 0000-0002-5007-2120
G J van LondenDepartment of Medicine, School of Medicine at the University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0001-6047-6172
Ishwaria M SubbiahDivision of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0002-0758-7911
Elizabeth HenryDivision of Hematology/Oncology, Department of Medicine, Loyola University Stritch School of Medicine, Maywood, IL.ORCID 0000-0003-2948-3985
Martina MurphyDivision of Hematology and Oncology, Department of Medicine, University of Florida College of Medicine, Gainesville, FL.
Maura M BarryDivision of Hematology and Oncology, The University of Vermont Larner College of Medicine, Burlington, VT.ORCID 0000-0003-0380-6934
Rami ManochakianDivision of Hematology and Oncology, Mayo Clinic, Jacksonville, FL.ORCID 0000-0001-9142-4113
Scott MoerdlerRutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.ORCID 0000-0002-2067-4817
Stacy LoebDepartment of Urology and Population Health, New York University and Manhattan Veterans Affairs, New York, NY.ORCID 0000-0003-3933-9207
Stephanie L GraffLifespan Cancer Institute at Brown University, Providence, RI.ORCID 0000-0003-1928-1722
Yan LeyfmanDepartment of Hematology-Oncology, Icahn School of Medicine at Mount Sinai, New York, NY.ORCID 0000-0002-9331-1857
Michael A ThompsonAurora Cancer Care, Advocate Aurora Health, Milwaukee, WI.ORCID 0000-0001-7930-4610
Merry J MarkhamDivision of Hematology and Oncology, Department of Medicine, University of Florida College of Medicine, Gainesville, FL.ORCID 0000-0003-3567-3494

Funding

The Collaboration for Outcomes using Social Media in Oncology (COSMO) ConferenceR13CA239613 · NCI · RHODE ISLAND HOSPITAL · PI DIZON, DON S · 2020 to 2020
$10k
NCI NIH HHS R13 CA239613
6 · The paper itself

Abstract

The use of social media continues to increase in health care and academia. Health care practice, particularly the oncologic field, is constantly changing because of new knowledge, evidence-based research, clinical trials, and government policies. Therefore, oncology trainees and professionals continue to strive to stay up-to-date with practice guidelines, research, and skills. Although social media as an educational and professional development tool is no longer completely new to medicine and has been embraced, it is still under-researched in terms of various outcomes. Social media plays several key roles in professional development and academic advancement. We reviewed the literature to evaluate how social media can be used for professional development and academic promotion of oncology professionals.

Indexed as

Social MediaDelivery of Health CareHumansMedical Oncology

Identifiers

PMID35312343
PMCPMC9377722

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.